Evidence map›Paper›PMID 30387376›Full record

ArticleMolecular pain

Differential modulation of voltage-gated sodium channels by nerve growth factor in three major subsets of TrkA-expressing nociceptors.

Irina Schaefer, Vincenzo Prato, Alice Arcourt, Francisco J Taberner, Stefan G Lechner

Open access · goldAbstract read
In one paragraph

Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Irina Schaefer1 Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Vincenzo Prato1 Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Alice Arcourt1 Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Francisco J Taberner1 Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Stefan G Lechner1 Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Heidelberg University · DEKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nerve growth factor is an inflammatory mediator that induces long-lasting hyperalgesia, which can partially be attributed to nerve growth factor-induced sensitization of primary afferent nociceptors. It was shown that nerve growth factor increases the excitability of polymodal C-fibre nociceptors by modulating tetrodotoxin-sensitive and tetrodotoxin-resistant voltage-gated sodium channels, but hitherto only little is known about the effects of nerve growth factor on sodium currents in other nociceptor subtypes that express the nerve growth factor receptor TrkA. We previously characterized two reporter mouse lines that allow the unequivocal identification of two important subclasses of TrkA-expressing nociceptors - i.e. neuropeptide Y receptor type 2 (NPY2R

Indexed as

Action PotentialsAnimalsAxonsGanglia, SpinalHyperalgesiaMice, TransgenicNerve Growth FactorNeuronsNociceptorsTetrodotoxinVoltage-Gated Sodium ChannelsNerve Growth FactorTetrodotoxinVoltage-Gated Sodium ChannelsA-fibre nociceptorhyperalgesianerve growth factorpainperipheral sensitizationsilent nociceptorVoltage-gated sodium channel

Identifiers

PMID30387376
PMCPMC6856966
OpenAlexW2898794158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.